Premium
Results of Gn RH Agonist Implants in Oestrous Induction and Oestrous Suppression in Bitches and Queens
Author(s) -
Maenhoudt C,
Santos NR,
Fontaine E,
Mir F,
Reynaud K,
Navarro C,
Fontbonne A
Publication year - 2012
Publication title -
reproduction in domestic animals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.546
H-Index - 66
eISSN - 1439-0531
pISSN - 0936-6768
DOI - 10.1111/rda.12041
Subject(s) - agonist , estrous cycle , reproduction , european union , medicine , gynecology , biology , receptor , business , ecology , economic policy
Contents Over the last 10–15 years, long‐acting Gn RH agonists have become widely available. In the field of small animal reproduction, most recent studies have focused on the use of two compounds developed under the form of subcutaneous implants: azagly‐nafarelin and deslorelin. Only the latter has been commercially available for use in male dogs, first in A ustralia and N ew Z ealand, then in several countries of the E uropean U nion since 2008. Although officially marketed for male dogs, this compound has also been studied in bitches and more recently in queens. Some published papers or recent presentations at congresses – still unpublished – have focused on the use of Gn RH agonists implants in females.